Comments
Loading...

Fulcrum Therapeutics

FULCNASDAQ
Logo brought to you by Benzinga Data
$4.55
-0.13-2.78%
At close: -
$4.72
0.173.74%
After Hours: Dec 24, 9:30 AM EDT

Fulcrum Therapeutics (NASDAQ:FULC) Stock Quotes, Forecast and News Summary

Fulcrum Therapeutics Stock (NASDAQ: FULC) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Jul
1
Aug
4
1
Sep
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.1
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$4.70
Close$4.55
Volume / Avg.729.74K / 1.04M
Day Range$4.35 - $4.82
52 Wk Range2.86 - 13.70
Market Cap$254.59M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
51
Short Interest
10.22%
Days to Cover5.44

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
FULC
AVIR

FAQ

Q

How do I buy Fulcrum Therapeutics (FULC) stock?

A

You can purchase shares of Fulcrum Therapeutics (NASDAQ:FULC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Fulcrum Therapeutics (FULC) competitors?

Q

What is the forecast, or price target, for Fulcrum Therapeutics (FULC) stock?

A

Fulcrum Therapeutics has a consensus price target of $7.50.

Q

What is the current price for Fulcrum Therapeutics (FULC)?

A

The stock price for Fulcrum Therapeutics (NASDAQ: FULC) is $4.72 last updated December 24, 2024 at 9:30 AM EST.

Q

Does Fulcrum Therapeutics (FULC) pay a dividend?

A

There are no upcoming dividends for Fulcrum Therapeutics.

Q

When is Fulcrum Therapeutics (NASDAQ:FULC) reporting earnings?

A

Fulcrum Therapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.

Q

Is Fulcrum Therapeutics (FULC) going to split?

A

There is no upcoming split for Fulcrum Therapeutics.

Q

What sector and industry does Fulcrum Therapeutics (FULC) operate in?

A

Fulcrum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch